Remove Healthcare Remove Healthcare Provider Remove Pharmaceutical manufacturing
article thumbnail

AI IN PHARMACEUTICAL MARKETING: Optimizing Automation and Expertise

PM360

AI supports marketers in key areas such as personalized campaigns (with tailored messages to healthcare professionals (HCPs) and patients), predictive analytics, and social sentiment analysis. Respondents cite workflow automation, data analysis, and realtime content generation as areas of interest within their organizations.

article thumbnail

Economics and risks of FDA’s Quality management maturity rating programme

European Pharmaceutical Review

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top-10 ways for Pharma to leverage AI according to…AI

Impetus Digital

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.

Pharma 92
article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines.

article thumbnail

Trends in Virtual Collaboration

Impetus Digital

In these online programs, a handful of carefully selected KOLs attending the congress are asked to summarize abstracts that will be of special interest to other healthcare providers from their country/region or specialty. In short, it is all about catering to different preferences at the same time.

article thumbnail

Getting ahead of regulatory changes around PFAS in pharmaceutical packaging

Clarivate

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.

article thumbnail

MEDICAL ADHERENCE – Tapping Into Provider-Patient Bonds

PM360

Improving our collective understanding of the patient’s overall healthcare experience is necessary to effectively deliver prescription support. Imagine a world where every patient leaves their provider’s office, not just with a prescription, but with a clear understanding of their medication, its benefits, and how to access it affordably.

Medical 52